The introduction of nicotinamide as a nicotine substitution in e-cigarette and smokeless items signifies a substantial regulatory challenge for that FDA. Nicotinamide does not have nicotinic receptor agonist activity and is thought to act as a sedative at significant dosages6. The claims created by Nicotine River, ECBlend, and other suppliers that